Adjuvant Therapies in the Treatment of Mandibular Necrosis: Case Reports
DOI:
https://doi.org/10.21270/archi.v14i1.6531Keywords:
Osteonecrosis, Osteoradionecrosis, Diagnosis, TherapyAbstract
Introduction: Maxillary necroses, whether medication-related osteonecrosis or osteoradionecrosis, are pathological conditions affecting patients who have undergone antiresorptive or angiogenesis-inhibiting therapy and radiation therapy in the head and neck region, respectively. Regarding medication-related osteonecrosis, the American Association of Oral and Maxillofacial Surgeons has established a staging classification based on clinical and imaging characteristics, guiding the treatment protocol. However, osteoradionecrosis does not have a single staging system; therefore, various classification methods have been reported, taking into account treatment response, disease status, and the extent of bone involvement. In light of this, the objective of this study is to report two clinical cases: the first diagnosed with stage II mandibular osteonecrosis associated with the use of denosumab, and the second with grade II mandibular osteoradionecrosis progressing to grade III, in which treatment was ineffective. Objeticve: Thus, this work encompasses not only the clinical and imaging aspects but also the clinical relevance of adjuvant therapies, the behavior of mandibular necroses, and the possibilities for definitive treatment.
Downloads
References
Pardo-Zamora G, Martínez Y, Moreno JA, Ortiz-Ruíz AJ. Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series. Int J Environ Res Public Health. 2021;18(3):1018.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014;72(10):1938-56.
AlDhalaan NA, BaQais A, Al-Omar A. Medication-related Osteonecrosis of the Jaw: A Review. Cureus. 2020;12(2):e6944.
Kubota H, Miyawaki D, Mukumoto N, Ishihara T, Matsumura M, Hasegawa T, Akashi M, Kiyota N, Shinomiya H, Teshima M, Nibu KI, Sasaki R. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol. 2021;16(1):1.
Regaud C. Sur la sensibilité du tissu osseux normal visà-vis des radiations X et je et sur le michanisme de losteoradionecrose: Comp Rend Soc Biol (Paris). 1922, 87:629-32.
Chronopoulos A, Zarra T, Ehrenfeld M, Otto S. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J. 2018;68(1):22-30.
Quah B, Yong CW, Lai CWM, Islam I. Efficacy of adjunctive modalities during tooth extraction for the prevention of osteoradionecrosis: A systematic review and meta-analysis. Oral Dis. 2024;30(6):3732-3744.
Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy: Head Neck. 2003, 25:181-6.
Almeida MVDC, Moura AC, Santos L, Gominho L, Cavalcanti UDNT, Romeiro K. Photodynamic Therapy as an adjunct in the Treatment of Medication-Related Osteonecrosis of the Jaw: A Case Report. J Lasers Med Sci. 2021;12:e12.
Frankart AJ, Frankart MJ, Cervenka B, Tang AL, Krishnan DG, Takiar V. Osteoradionecrosis: Exposing the Evidence Not the Bone. Int J Radiat Oncol Biol Phys. 2021;109(5):1206-1218.
Andrade IP, Xavier K, Nunes A, Fardin RF. Concentração inibitória mínima de antissépticos bucais em microorganismos da cavidade oral. RBPS. 2011;13(3):10-16.
Minamisako MC, Ribeiro GH, Lisboa ML, Mariela Rodríguez Cordeiro M, Grando LJ. Medication-Related Osteonecrosis of Jaws: A Low-Level Laser Therapy and Antimicrobial Photodynamic Therapy Case Approach. Case Rep Dent. 2016;2016:6267406.
